Results 191 to 200 of about 147,443 (317)

Identification of functional murine mitochondrial formyl peptides and their effects on myeloid‐derived suppressor cell generation

FEBS Open Bio, EarlyView.
We first identified functional murine mitochondrial N‐formyl peptides (MT‐FPs) and investigated their effects on the in vitro myeloid‐derived suppressor cell (MDSC) generation from bone marrow cells. We demonstrated that MT‐FPs acted directly on bone marrow cells to promote MDSC generation and modulated the polymorphonuclear (PMN)‐MDSC/monocyte (M ...
Miyako Ozawa, Saori Kagoshima, Akira Yamada   +2 more
wiley   +1 more source

ADN tumoral circulante en pacientes con cáncer: perspectivas desde el laboratorio clínico. [PDF]

Adv Lab Med
Illana FJ, Fernández-Galán E, Muñoz-Bravo JL, Amado LV, García Martín C, González-Fernández C, Miró-Cañís S, Trapé J, Martínez-Peinado A, Filella X, González A, Barco Sánchez A, Díaz-Lagares A, en nombre de la Comisión de Marcadores Biológicos del Cáncer de la Sociedad Española de Medicina de Laboratorio.   +13 more
europepmc   +1 more source

Tumores neuro-endócrinos do Pâncreas [PDF]

, 2014
Inês Barbosa Santos de Aguiar Pereira
core  

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

[Prevalence of Esophageal Squamous Cell Carcinoma among Patients with Head and Neck Cancer: A Single-Center Study]. [PDF]

Acta Gastroenterol Latinoam
Martins Lima AV, Carvalho Franco F, Quevedo Penaloza CS, Cadena Aguirre D, Sartori Balbinot R, Rie Imada R, Marioni F, Nobre Moura R, Andrade de Paulo G, Vaz Safatle-Ribeiro A, Menezes da Cunha L, Gonçalves Ferreira F.   +11 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

[Brown tumor due to hyperparathyroidism secondary to chronic kidney disease: A clinical case]. [PDF]

Rev Med Inst Mex Seguro Soc
Contreras-Vargas LM, Sánchez-Cuevas M, Haro-Sandoval Y, Paque-Bautista C, González AP, Reyes-Sosa AM, Flores-Rodríguez R, Murguía-Pérez M, Guisao-Valencia CA, Sosa-Bustamante GP.   +9 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

[Primary testicular lymphoma with extranodal involvement in the stomach. Case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Díaz-Fuentes H.
europepmc   +1 more source

Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells

FEBS Open Bio, EarlyView.
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel, Sam Bennett, Natalie Ehlinger, Nelson Cook, Katelyn Marvin, Caleb L. Lines, Sam Reyes, Brooke Kirby, Shawn M. Ellerbroek   +8 more
wiley   +1 more source